Literature DB >> 20978200

Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity.

Helen Trottier1, Silvaneide Ferreira, Patricia Thomann, Maria C Costa, Joao S Sobrinho, José Carlos M Prado, Thomas E Rohan, Luisa L Villa, Eduardo L Franco.   

Abstract

There is a paucity of data on whether or not women can be reinfected with human papillomavirus (HPV) types to which they were exposed to earlier in life and on the role of natural immunity. The observation of HPV infection at older ages may be explained by the reactivation of a latent infection or new exposure from sexual activity. Our objective was to analyze the association between reinfection and sexual activity. We analyzed data from 2,462 women enrolled in the Ludwig-McGill cohort and followed every 4 to 6 months for up to 10 years. We performed HPV typing and viral load measurements via PCR and determined HPV-16 seroreactivity at enrollment. Incidence of infection and reinfection were estimated for individual types. Adjusted relative risks (RR) for the association between infection/reinfection and new sexual partners were calculated using Cox regression. Rates of initial infection and reinfection postclearance were statistically comparable. RRs of initial infection or reinfection were consistently associated with new sexual partners [2.4 (95% confidence intervals; 95% CI, 2.0-3.1) for first infection, 3.7 (1.1-13.8) for reinfection with the same type, and 2.3 (1.5-3.7) for reinfection with a different type]. Reinfection in older women was also associated with new sexual partners (RR, 2.8; 95% CI, 1.4-5.3) as were new infections with HPV-16 among women with serologic evidence of prior HPV-16 exposure (RR, 3.0; 95% CI, 1.6-5.3). Viral loads at initial infection and at reinfection were comparable. HPV infection and reinfection were strongly associated with sexual activity. This study suggests that natural immunity does not play a role in controlling the extent of reinfections. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978200      PMCID: PMC4068337          DOI: 10.1158/0008-5472.CAN-10-0621

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.

Authors:  Sven-Eric Olsson; Susanne K Kjaer; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricia García; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Matti Lehtinen; Marc Steben; F Xavier Bosch; Joakim Dillner; Elmar A Joura; Slawomir Majewski; Nubia Muñoz; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine Bryan; Roger Maansson; Scott Vuocolo; Teresa M Hesley; Alfred Saah; Eliav Barr; Richard M Haupt
Journal:  Hum Vaccin       Date:  2009-10-01

2.  Viral load as a predictor of the risk of cervical intraepithelial neoplasia.

Authors:  Nicolas F Schlecht; Andrea Trevisan; Eliane Duarte-Franco; Thomas E Rohan; Alex Ferenczy; Luisa L Villa; Eduardo L Franco
Journal:  Int J Cancer       Date:  2003-02-10       Impact factor: 7.396

3.  Epidemiology of HPV infection among Mexican women with normal cervical cytology.

Authors:  E Lazcano-Ponce; R Herrero; N Muñoz; A Cruz; K V Shah; P Alonso; P Hernández; J Salmerón; M Hernández
Journal:  Int J Cancer       Date:  2001-02-01       Impact factor: 7.396

4.  Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.

Authors:  E Franco; L Villa; T Rohan; A Ferenczy; M Petzl-Erler; G Matlashewski
Journal:  Rev Panam Salud Publica       Date:  1999-10

5.  Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.

Authors:  R Herrero; A Hildesheim; C Bratti; M E Sherman; M Hutchinson; J Morales; I Balmaceda; M D Greenberg; M Alfaro; R D Burk; S Wacholder; M Plummer; M Schiffman
Journal:  J Natl Cancer Inst       Date:  2000-03-15       Impact factor: 13.506

6.  High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse).

Authors:  S K Kjaer; B Chackerian; A J van den Brule; E I Svare; G Paull; J M Walbomers; J T Schiller; J E Bock; M E Sherman; D R Lowy; C L Meijer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-02       Impact factor: 4.254

7.  General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas.

Authors:  A J van den Brule; P J Snijders; R L Gordijn; O P Bleker; C J Meijer; J M Walboomers
Journal:  Int J Cancer       Date:  1990-04-15       Impact factor: 7.396

8.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

9.  Human papillomavirus: epidemiology and public health.

Authors:  Mark Schiffman; Philip E Castle
Journal:  Arch Pathol Lab Med       Date:  2003-08       Impact factor: 5.534

Review 10.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

View more
  55 in total

1.  Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection.

Authors:  Lauren Wilson; Michael Pawlita; Phillip E Castle; Tim Waterboer; Vikrant Sahasrabuddhe; Patti E Gravitt; Mark Schiffman; Nicolas Wentzensen
Journal:  J Infect Dis       Date:  2014-02-25       Impact factor: 5.226

2.  Genital transmission of human papillomavirus in recently formed heterosexual couples.

Authors:  Ann N Burchell; François Coutlée; Pierre-Paul Tellier; James Hanley; Eduardo L Franco
Journal:  J Infect Dis       Date:  2011-10-07       Impact factor: 5.226

3.  Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Diane Solomon; Diego Guillén; Mario Alfaro; Jorge Morales; Martha Hutchinson; Li Cheung; Sholom Wacholder; Robert D Burk
Journal:  Int J Cancer       Date:  2012-02-28       Impact factor: 7.396

Review 4.  Human papillomavirus: what every provider should know.

Authors:  Britt K Erickson; Ronald D Alvarez; Warner K Huh
Journal:  Am J Obstet Gynecol       Date:  2012-09-14       Impact factor: 8.661

5.  Cervical ectopy and the acquisition of human papillomavirus in adolescents and young women.

Authors:  Loris Y Hwang; Jay A Lieberman; Yifei Ma; Sepideh Farhat; Anna-Barbara Moscicki
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

6.  A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States.

Authors:  Patti E Gravitt; Anne F Rositch; Michelle I Silver; Morgan A Marks; Kathryn Chang; Anne E Burke; Raphael P Viscidi
Journal:  J Infect Dis       Date:  2012-12-12       Impact factor: 5.226

7.  Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.

Authors:  Tsung-Chieh Jane Fu; Joseph J Carter; James P Hughes; Qinghua Feng; Stephen E Hawes; Stephen M Schwartz; Long Fu Xi; Taylor Lasof; Joshua E Stern; Denise A Galloway; Laura A Koutsky; Rachel L Winer
Journal:  Int J Cancer       Date:  2016-08-04       Impact factor: 7.396

8.  Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals.

Authors:  Lea Widdice; Yifei Ma; Janet Jonte; Sepideh Farhat; David Breland; Stephen Shiboski; Anna-Barbara Moscicki
Journal:  J Infect Dis       Date:  2013-01-14       Impact factor: 5.226

Review 9.  HPV-FASTER: broadening the scope for prevention of HPV-related cancer.

Authors:  F Xavier Bosch; Claudia Robles; Mireia Díaz; Marc Arbyn; Iacopo Baussano; Christine Clavel; Guglielmo Ronco; Joakim Dillner; Matti Lehtinen; Karl-Ulrich Petry; Mario Poljak; Susanne K Kjaer; Chris J L M Meijer; Suzanne M Garland; Jorge Salmerón; Xavier Castellsagué; Laia Bruni; Silvia de Sanjosé; Jack Cuzick
Journal:  Nat Rev Clin Oncol       Date:  2015-09-01       Impact factor: 66.675

10.  Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Sepideh Farhat; Teresa M Darragh; Michael Pawlita; Denise A Galloway; Stephen Shiboski
Journal:  J Infect Dis       Date:  2013-04-18       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.